Literature DB >> 31185392

Bridged bicyclic 2,3-dioxabicyclo[3.3.1]nonanes as antiplasmodial agents: Synthesis, structure-activity relationships and studies on their biomimetic reaction with Fe(II).

Sarah D'Alessandro1, Gloria Alfano2, Luisa Di Cerbo2, Simone Brogi2, Giulia Chemi2, Nicola Relitti2, Margherita Brindisi3, Stefania Lamponi2, Ettore Novellino3, Giuseppe Campiani4, Sandra Gemma5, Nicoletta Basilico1, Donatella Taramelli6, Maria Camilla Baratto2, Rebecca Pogni2, Stefania Butini2.   

Abstract

Despite recent advancements in its control, malaria is still a deadly parasitic disease killing millions of people each year. Progresses in combating the infection have been made by using the so-called artemisinin combination therapies (ACTs). Natural and synthetic peroxides are an important class of antimalarials. Here we describe a new series of peroxides synthesized through a new elaboration of the scaffold of bicyclic-fused/bridged synthetic endoperoxides previously developed by us. These peroxides are produced by a straightforward synthetic protocol and are characterized by submicromolar potency when tested against both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum strains. To investigate their mode of action, the biomimetic reaction of the representative compound 6w with Fe(II) was studied by EPR and the reaction products were characterized by NMR. Rationalization of the observed structure-activity relationship studies was performed by molecular docking. Taken together, our data robustly support the hypothesized mode of activation of peroxides 6a-cc and led to the definition of the key structural requirements responsible for the antiplasmodial potency. These data will pave the way in future to the rational design of novel optimized antimalarials suitable for in vivo investigation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimalarials; Bioactivation reaction; C-centered radicals; Docking studies; Plasmodium falciparum; Synthetic endoperoxides

Mesh:

Substances:

Year:  2019        PMID: 31185392     DOI: 10.1016/j.bioorg.2019.103020

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  1 in total

1.  A Repurposing Approach for Uncovering the Anti-Tubercular Activity of FDA-Approved Drugs with Potential Multi-Targeting Profiles.

Authors:  Basem Battah; Giulia Chemi; Stefania Butini; Giuseppe Campiani; Simone Brogi; Giovanni Delogu; Sandra Gemma
Journal:  Molecules       Date:  2019-11-29       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.